The homophilic interactions of CEACAM1, occurring between CEACAM1+ TILs, and CEACAM1+ tumor cells, as well as the interaction of CbpF with CEACAM1 expressed on NK and T cells, may protect tumors from killing by these immune cells in a synergistic mechanism. Here, CEACAM1 is linked to neoplasm.